Johnson & Johnson in talks to acquire Protagonist Therapeutics, source says

Reported about 6 hours ago

Writing summary...

You may also interested in these wikis

Realty Income Issues $800 Million in Notes, Cramer Shows Support

JPMorgan Lowers Price Target for Immunovant (IMVT) to $33

Vietnam Achieves Emerging Market Status, Drawing Global Investment

AP Financial Headlines Update

Gold Prices Decline After Soaring to Record High

Bank of America Securities Remains Positive on Ultragenyx Pharmaceutical (RARE)

CPI Report Will Shine Light On Economy During Data Blackout

China Enforces Stricter Rare Earth Export Regulations Targeting Military and Tech Sectors

Tesla's New Affordable EVs Still More Expensive Than Previous Models

Healthcare Stocks Show Potential: Focus on CRISPR and BioNTech

Back to all Wikis